Christian Brambilla focuses on Cancer research, Lung cancer, Pathology, Cancer and Adenocarcinoma. His Cancer research study combines topics in areas such as Gene expression profiling, Transcriptome, Tumor suppressor gene, Histone and Epigenetics. His Lung cancer study is related to the wider topic of Internal medicine.
In his study, Predictive marker, Atypical adenomatous hyperplasia and KRAS is strongly linked to Oncology, which falls under the umbrella field of Internal medicine. His Pathology research incorporates elements of Receptor and Angiogenesis. His Adenocarcinoma research includes themes of Lung, Proto-oncogene tyrosine-protein kinase Src and Gefitinib.
Christian Brambilla mostly deals with Lung cancer, Pathology, Cancer research, Internal medicine and Cancer. His Lung cancer research focuses on subjects like Adenocarcinoma, which are linked to Gene expression. His Pathology study integrates concerns from other disciplines, such as Respiratory disease, Lung and Large cell.
While the research belongs to areas of Cancer research, Christian Brambilla spends his time largely on the problem of Cell, intersecting his research to questions surrounding Molecular biology. The Internal medicine study combines topics in areas such as Gastroenterology, Surgery and Oncology. Christian Brambilla works mostly in the field of Cancer, limiting it down to concerns involving DNA methylation and, occasionally, Regulation of gene expression.
Christian Brambilla focuses on Cancer research, Lung cancer, Cancer, Internal medicine and Oncology. His work deals with themes such as Cell, E2F1, Downregulation and upregulation, Gene and Cyclin E, which intersect with Cancer research. Lung cancer is a subfield of Pathology that he studies.
He has researched Cancer in several fields, including Respiratory disease, Regulation of gene expression and Somatic cell. His Oncology study combines topics from a wide range of disciplines, such as Progressive disease, Genotyping, Primary tumor, Metastasis and Survival analysis. His study in Adenocarcinoma is interdisciplinary in nature, drawing from both Angiogenesis, Gene expression, KRAS, Lung and Gefitinib.
His primary areas of study are Cancer research, Cancer, Lung cancer, Adenocarcinoma and Internal medicine. His Cancer research study combines topics in areas such as Gene expression profiling, E2F1, Apoptosis and Epigenetics, Gene. His Cancer research includes elements of Pathology, Ectopic expression, Bioinformatics and Somatic cell.
His studies in Lung cancer integrate themes in fields like Biomarker and Circulating free DNA. The various areas that Christian Brambilla examines in his Adenocarcinoma study include Lung, Erlotinib and Gefitinib. His studies link Oncology with Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
William D Travis;Elisabeth Brambilla;Masayuki Noguchi;Andrew G Nicholson.
Journal of Thoracic Oncology (2011)
American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias
William D. Travis;Talmadge E. King;Eric D. Bateman;David A. Lynch.
American Journal of Respiratory and Critical Care Medicine (2002)
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
Martin Peifer;Lynnette Fernández-Cuesta;Martin L. Sos;Julie George.
Nature Genetics (2012)
Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer
Jonathan Weiss;Martin L. Sos;Danila Seidel;Martin Peifer.
Science Translational Medicine (2010)
A genomics-based classification of human lung tumors
Danila Seidel;Thomas Zander;Lukas C. Heukamp;Martin Peifer.
Science Translational Medicine (2013)
Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer
Peter S. Hammerman;Martin L. Sos;Alex H. Ramos;Chunxiao Xu.
Cancer Discovery (2011)
In situ apoptotic cell labeling by the TUNEL method: improvement and evaluation on cell preparations.
A Negoescu;P Lorimier;F Labat-Moleur;C Drouet.
Journal of Histochemistry and Cytochemistry (1996)
Exposure to Phthalates and Phenols during Pregnancy and Offspring Size at Birth
Claire Philippat;Marion Mortamais;Cécile Chevrier;Claire Petit.
Environmental Health Perspectives (2011)
Ectopic Activation of Germline and Placental Genes Identifies Aggressive Metastasis-Prone Lung Cancers
Sophie Rousseaux;Alexandra Debernardi;Baptiste Jacquiau;Anne Laure Vitte.
Science Translational Medicine (2013)
Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors.
E. Brambilla;A. Negoescu;S. Gazzeri;S. Lantuejoul.
American Journal of Pathology (1996)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: